An Orange County school district has announced it will no longer use the “Raiders” name for its athletic teams following ...

This was the stock's sixth consecutive day of losses.

This was the stock's fifth consecutive day of losses.

Truist Financial analyst Michael Lewis maintained a Hold rating on AvalonBay (AVB – Research Report) today and set a price target of $230.00.

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

NEWARK, Del., Feb. 27, 2025 /PRNewswire/ -- Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced today that the U.S. Food and Drug Administration (FDA) has granted ...

The sale is expected to close on or around March 31. In addition, AVB entered into an agreement with BSR REIT, BSR Trust and certain holders of Class B units of BSR Trust to purchase six ...

Compelling results from a Mayo Clinic Phase I trial ("STOMP-I") led to the founding of Avobis Bio and primary endpoint results from the Phase II trial ("STOMP-II) of AVB-114 are expected in mid-2025.

Andre Villas-Boas spent less than a year in charge of Chelsea (Picture: Getty) In an interview with Stadium Astro, Obi Mikel was asked: ‘AVB, what were your impressions of him when he joined?

AvalonBay Communities, Inc. is a real estate investment trust, which engages in the development, acquisition, ownership, and operation of multifamily communities. It operates through the following ...